Aspire Health vs Cora Health
These are the two most transparent providers in this directory, and they express it differently. Aspire tells you the price of every single dose, including brand-name alternatives. Cora tells you one number that never changes and names the pharmacy that makes your medication.
Last updated August 5, 2026
Side by side
| Dimension | Aspire Health | Cora Health |
|---|---|---|
| Compounded semaglutide | $129-$189 per vial by dose, plus $49/month care | $99-$175/month all-inclusive by plan length |
| Compounded tirzepatide | $149-$299 per vial by dose, plus $49/month care | $135-$225/month all-inclusive by plan length |
| Price at maintenance dose | Rises with dose — $299 per vial at 12.5-15mg tirzepatide | Flat — never increases with dose |
| Brand-name option | Wegovy $199-$399 and Zepbound $299-$449, fully priced | None — compounded only |
| Pharmacy disclosure | Not named | Hallandale Pharmacy and VialsRx (503A), named |
| Published eligibility | BMI over 27 likely qualifies, stated | Not published |
| Consultation | Free, with pay-only-if-you-proceed | Included in the plan price; ~24-hour provider review |
| Upfront commitment | None stated — per-vial with bundles available | Best rates require $1,188-$1,620 prepaid |
| HSA/FSA | Accepted, explicitly including compounded medication | Accepted |
| Cancellation terms | Not published | Cancel or pause by messaging the care team; published policy |
Highlighted cells indicate the stronger position on that dimension only. Facts are taken from each provider's own published materials and are recorded in full on their individual review pages.
Choose Aspire Health if…
- You want to compare compounded against brand-name with real numbers
- You want to start without prepaying a year
- You want a free consultation before spending anything
- You want a published BMI threshold before you apply
Choose Cora Health if…
- You expect to titrate to a high dose and want the price to hold
- You want to know which pharmacy compounds your medication
- You can commit to six or twelve months for the lowest total cost
- You want published cancellation terms before enrolling
Our verdict
Cora wins on cost at any therapeutic dose — its flat rate means 15mg tirzepatide costs the same $135/month as 2.5mg, where Aspire charges $299 per vial plus $49 care at that dose. It also names its pharmacies and publishes cancellation terms. Aspire wins on informed decision-making: it is the only provider we have found that prices every dose of both compounded and brand-name product, so you can see exactly what you gain or give up by choosing one over the other, and its free consultation and published BMI threshold mean nothing is spent before you know you qualify. Cost-optimisers should take Cora; anyone still deciding between compounded and brand-name should start at Aspire.
Frequently asked questions
Which is actually cheaper?
Cora, at any dose above the entry level. Cora's flat rate holds at $99-$175/month for semaglutide and $135-$225 for tirzepatide regardless of dose. Aspire charges per vial by dose plus a $49/month care fee, so at 12.5mg tirzepatide you would pay $299 plus $49 against Cora's flat $135 on an annual plan.
Why choose Aspire then?
Because it prices brand-name Wegovy and Zepbound alongside its compounded products, so you can make the compounded-versus-FDA-approved decision with real numbers. It also requires no upfront commitment, offers a free consultation you only pay for if you proceed, and publishes a BMI eligibility threshold.
Compare more options
Medical disclaimer
This comparison is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Only a licensed clinician who has evaluated you can decide whether any medication is appropriate. Pricing, medication availability, pharmacy partners and policies change frequently and vary by state — verify everything directly with the provider before purchasing.